← Leaderboards
Suvra Pal
University Of Massachusetts Amherst
$912,411
Attributed
$1,276,861
Total exposure
3
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $452.1K · FY2019–25$500K$375K$250K$125K$0
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$1,276,861 · 3
By mechanism
R21$546,675 · 1
R15$452,082 · 1
R35$278,104 · 1
Top collaborators
- Souvik Roy3 shared
- Leili Shahriyari3 shared
Most similar at University Of Massachusetts Amherst
Same institution · by research overlap
- Patty S. Freedson$4,759,487
- John W Staudenmayer$2,495,595
- Sunghoon Lee$3,623,970
- Yeonsik Noh$2,268,662
- Sridhar Mahadevan$1,969,124
Others in their field
Other Emerging Leaders on “Biological”
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Leonard Freedman · Leidos Biomedical Research, Inc.$377,088,269
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$343,713,561
- Chanza Baytop · Westat, Inc.$271,217,917
- Lynn Briscoe · Leidos Biomedical Research, Inc.$149,803,496
Research focus
BiologicalCharacteristicsPatternCessation Of LifeComplexComputer SoftwareData SetOptimal TreatmentsTreatment StrategyVariantInnovationAlgorithmsModel BuildingAffectCancer TypeColon Cancer TreatmentCancer TherapyAnimalsColon Cancer PatientsColonic NeoplasmsAlternative TherapiesAdoptedCancer EtiologyCell Type
Grant awards (5)
Machine Learning-Based Predictive Models for Disease Cure and Computationally Efficient Methods in High-Dimensional Settings$278,104
R35 · FY2025 · GM · contact PI
Using Machine Learning to Improve the Predictive Accuracy of Disease Cure$452,082
R15 · FY2023 · GM · contact PI
Data-driven QSP software for personalized colon cancer treatment$202,044
R21 · FY2020 · CA
Data-driven QSP software for personalized colon cancer treatment$159,908
R21 · FY2020 · CA
Data-driven QSP software for personalized colon cancer treatment$184,723
R21 · FY2019 · CA